# GEN Restaurant Group, Inc.: financial statements, quarterly

GENK · Nasdaq · CIK 1891856 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/genk.md) · [Financials](/companies/genk/financials.md) · [Filings](/companies/genk/filings.md) · [Insiders](/companies/genk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/genk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [45.6](/filings/0000950170-24-125450.md) | [45.1 d](/filings/0000950170-25-035772.md) | [50.8](/filings/0000950170-25-070379.md) | [53.9](/filings/0000950170-25-104061.md) | [49.1](/filings/0001193125-25-272354.md) | [54.7 d](/filings/0001193125-26-134555.md) | [57.3](/filings/0001193125-26-224023.md) | [55.0](/filings/0001193125-26-342538.md) | [50.4](/filings/0001193125-25-272354.md) | [49.7 d](/filings/0001193125-26-134555.md) | [53.9](/filings/0001193125-26-224023.md) | [55.7](/filings/0001193125-26-342538.md) |
| Operating income | $m | [2.5](/filings/0000950170-24-125450.md) | [(0.9) d](/filings/0000950170-25-035772.md) | [0.1](/filings/0000950170-25-070379.md) | [1.6](/filings/0000950170-25-104061.md) | [0.1](/filings/0001193125-25-272354.md) | [(1.3) d](/filings/0001193125-26-134555.md) | [(2.2)](/filings/0001193125-26-224023.md) | [(1.9)](/filings/0001193125-26-342538.md) | [(3.7)](/filings/0001193125-25-272354.md) | [(12.2) d](/filings/0001193125-26-134555.md) | [(7.2)](/filings/0001193125-26-224023.md) | [(5.2)](/filings/0001193125-26-342538.md) |
| Interest expense | $m | [0.2](/filings/0000950170-23-063843.md) | [(0.1) d](/filings/0000950170-24-027323.md) | [0.1](/filings/0000950170-24-059545.md) | [0.1](/filings/0000950170-24-088608.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0000950170-24-125450.md) | [(0.2) d](/filings/0000950170-25-035772.md) | [0.1](/filings/0000950170-25-070379.md) | [0.0](/filings/0000950170-25-104061.md) | [0.1](/filings/0001193125-25-272354.md) | [0.2 d](/filings/0001193125-26-134555.md) | [(0.2)](/filings/0001193125-26-224023.md) | [(0.1)](/filings/0001193125-26-342538.md) | [(0.3)](/filings/0001193125-25-272354.md) | [(0.4) d](/filings/0001193125-26-134555.md) | [(0.3)](/filings/0001193125-26-224023.md) | [(0.2)](/filings/0001193125-26-342538.md) |
| Net income | $m | [0.3](/filings/0000950170-24-125450.md) | [(0.0) d](/filings/0000950170-25-035772.md) | [0.5](/filings/0000950170-25-070379.md) | [0.3](/filings/0000950170-25-104061.md) | [0.0](/filings/0001193125-25-272354.md) | [(0.2) d](/filings/0001193125-26-134555.md) | [(0.3)](/filings/0001193125-26-224023.md) | [(0.3)](/filings/0001193125-26-342538.md) | [(0.6)](/filings/0001193125-25-272354.md) | [(1.9) d](/filings/0001193125-26-134555.md) | [(1.2)](/filings/0001193125-26-224023.md) | [(0.8)](/filings/0001193125-26-342538.md) |
| Diluted EPS | $ per share | [0.08](/filings/0000950170-24-125450.md) | not reported | [0.11](/filings/0000950170-25-070379.md) | [0.06](/filings/0000950170-25-104061.md) | [0.01](/filings/0001193125-25-272354.md) | not reported | [(0.06)](/filings/0001193125-26-224023.md) | [(0.05)](/filings/0001193125-26-342538.md) | [(0.11)](/filings/0001193125-25-272354.md) | not reported | [(0.22)](/filings/0001193125-26-224023.md) | [(0.14)](/filings/0001193125-26-342538.md) |
| Basic EPS | $ per share | [0.08](/filings/0000950170-24-125450.md) | not reported | [0.11](/filings/0000950170-25-070379.md) | [0.06](/filings/0000950170-25-104061.md) | [0.01](/filings/0001193125-25-272354.md) | not reported | [(0.06)](/filings/0001193125-26-224023.md) | [(0.05)](/filings/0001193125-26-342538.md) | [(0.11)](/filings/0001193125-25-272354.md) | not reported | [(0.22)](/filings/0001193125-26-224023.md) | [(0.14)](/filings/0001193125-26-342538.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.1](/filings/0000950170-23-063843.md) | [32.6](/filings/0000950170-25-035772.md) | [28.1](/filings/0000950170-24-059545.md) | [29.2](/filings/0000950170-24-088608.md) | [22.1](/filings/0000950170-24-125450.md) | [23.7](/filings/0001193125-26-134555.md) | [15.4](/filings/0000950170-25-070379.md) | [9.6](/filings/0000950170-25-104061.md) | [4.8](/filings/0001193125-25-272354.md) | [2.8](/filings/0001193125-26-342538.md) | [4.4](/filings/0001193125-26-224023.md) | [5.9](/filings/0001193125-26-342538.md) |
| Current assets | $m | [35.8](/filings/0000950170-23-063843.md) | [36.8](/filings/0000950170-25-035772.md) | [32.5](/filings/0000950170-24-059545.md) | [33.0](/filings/0000950170-24-088608.md) | [29.5](/filings/0000950170-24-125450.md) | [33.9](/filings/0001193125-26-134555.md) | [22.3](/filings/0000950170-25-070379.md) | [16.8](/filings/0000950170-25-104061.md) | [13.2](/filings/0001193125-25-272354.md) | [22.7](/filings/0001193125-26-342538.md) | [15.2](/filings/0001193125-26-224023.md) | [16.8](/filings/0001193125-26-342538.md) |
| Total assets | $m | [176](/filings/0000950170-23-063843.md) | [184](/filings/0000950170-25-035772.md) | [215](/filings/0000950170-24-059545.md) | [219](/filings/0000950170-24-088608.md) | [226](/filings/0000950170-24-125450.md) | [240](/filings/0001193125-26-134555.md) | [232](/filings/0000950170-25-070379.md) | [246](/filings/0000950170-25-104061.md) | [246](/filings/0001193125-25-272354.md) | [260](/filings/0001193125-26-342538.md) | [259](/filings/0001193125-26-224023.md) | [248](/filings/0001193125-26-342538.md) |
| Current liabilities | $m | [24.9](/filings/0000950170-23-063843.md) | [31.3](/filings/0000950170-25-035772.md) | [34.1](/filings/0000950170-24-059545.md) | [31.3](/filings/0000950170-24-088608.md) | [32.2](/filings/0000950170-24-125450.md) | [41.1](/filings/0001193125-26-134555.md) | [35.0](/filings/0000950170-25-070379.md) | [37.9](/filings/0000950170-25-104061.md) | [40.5](/filings/0001193125-25-272354.md) | [54.1](/filings/0001193125-26-342538.md) | [53.1](/filings/0001193125-26-224023.md) | [58.5](/filings/0001193125-26-342538.md) |
| Total liabilities | $m | [139](/filings/0000950170-23-063843.md) | [146](/filings/0000950170-25-035772.md) | [173](/filings/0000950170-24-059545.md) | [171](/filings/0000950170-24-088608.md) | [178](/filings/0000950170-24-125450.md) | [195](/filings/0001193125-26-134555.md) | [188](/filings/0000950170-25-070379.md) | [204](/filings/0000950170-25-104061.md) | [206](/filings/0001193125-25-272354.md) | [232](/filings/0001193125-26-342538.md) | [238](/filings/0001193125-26-224023.md) | [230](/filings/0001193125-26-342538.md) |
| Long-term debt | $m | [4.7](/filings/0000950170-23-063843.md) | [4.5](/filings/0000950170-24-027323.md) | [4.4](/filings/0000950170-24-059545.md) | [4.4](/filings/0000950170-24-088608.md) | [5.6](/filings/0000950170-24-125450.md) | [5.1](/filings/0000950170-25-035772.md) | [4.7](/filings/0000950170-25-070379.md) | [4.9](/filings/0000950170-25-104061.md) | [6.1](/filings/0001193125-25-272354.md) | [10.8](/filings/0001193125-26-134555.md) | [11.1](/filings/0001193125-26-224023.md) | [9.2](/filings/0001193125-26-342538.md) |
| Current portion of debt | $m | [0.0](/filings/0000950170-23-063843.md) | [0.2](/filings/0000950170-24-027323.md) | [3.3](/filings/0000950170-24-059545.md) | [3.2](/filings/0000950170-24-088608.md) | [1.7](/filings/0000950170-24-125450.md) | [1.7](/filings/0000950170-25-035772.md) | [1.8](/filings/0000950170-25-070379.md) | [2.9](/filings/0000950170-25-104061.md) | [4.7](/filings/0001193125-25-272354.md) | [2.8](/filings/0001193125-26-134555.md) | [1.4](/filings/0001193125-26-224023.md) | [2.8](/filings/0001193125-26-342538.md) |
| Shareholders' equity | $m | [35.0](/filings/0000950170-24-125450.md) | [36.0](/filings/0001193125-25-272354.md) | [40.4](/filings/0001193125-25-272354.md) | [45.9](/filings/0001193125-25-272354.md) | [46.5](/filings/0001193125-25-272354.md) | [44.1](/filings/0001193125-26-342538.md) | [42.8](/filings/0001193125-26-342538.md) | [41.0](/filings/0001193125-26-342538.md) | [38.1](/filings/0001193125-25-272354.md) | [26.5](/filings/0001193125-26-342538.md) | [19.9](/filings/0001193125-26-342538.md) | [16.0](/filings/0001193125-26-342538.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,938 d](/filings/0000950170-24-125450.md) | [8,678 d](/filings/0000950170-25-035772.md) | [3,514](/filings/0000950170-25-070379.md) | [5,556 d](/filings/0000950170-25-104061.md) | [1,449 d](/filings/0001193125-25-272354.md) | [7,308 d](/filings/0001193125-26-134555.md) | [2,154](/filings/0001193125-26-224023.md) | [3,326 d](/filings/0001193125-26-342538.md) | [(1,640) d](/filings/0001193125-25-272354.md) | [(426) d](/filings/0001193125-26-134555.md) | [2,685](/filings/0001193125-26-224023.md) | [(3,511) d](/filings/0001193125-26-342538.md) |
| Capital expenditure | $k | [4,617 d](/filings/0000950170-24-125450.md) | [7,695 d](/filings/0000950170-25-035772.md) | [4,100](/filings/0000950170-25-070379.md) | [4,307 d](/filings/0000950170-25-104061.md) | [8,275 d](/filings/0001193125-25-272354.md) | [7,143 d](/filings/0001193125-26-134555.md) | [6,829](/filings/0001193125-26-224023.md) | [9,638 d](/filings/0001193125-26-342538.md) | [6,056 d](/filings/0001193125-25-272354.md) | [5,211 d](/filings/0001193125-26-134555.md) | [3,352](/filings/0001193125-26-224023.md) | [1,966 d](/filings/0001193125-26-342538.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-272354.md) | [0.0 d](/filings/0001193125-26-134555.md) | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | [200](/filings/0001193125-26-224023.md) | [0.0 d](/filings/0001193125-26-342538.md) | [0.0 d](/filings/0001193125-25-272354.md) | [1.0 d](/filings/0001193125-26-134555.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-06-30) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [0.0](/filings/0000950170-23-042466.md) | [4,249](/filings/0000950170-24-088608.md) | [4,140](/filings/0000950170-24-125450.md) | [4,324](/filings/0000950170-25-070379.md) | [4,572](/filings/0000950170-25-104061.md) | [4,861](/filings/0001193125-25-272354.md) | [5,013](/filings/0001193125-26-224023.md) | [5,132](/filings/0001193125-26-342538.md) | [5,245](/filings/0001193125-25-272354.md) | [5,332](/filings/0001193125-26-224023.md) | [5,364](/filings/0001193125-26-342538.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.